Related Experiment Video
Updated: Jun 18, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Activating mutations in TOR are in similar structures as oncogenic mutations in PI3KCalpha
Thomas W Sturgill1, Michael N Hall
1Department of Pharmacology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA. tws7w@virginia.edu
ACS Chemical Biology
|November 12, 2009
Summary
Target of Rapamycin (TOR) kinase, a cell growth controller, was modeled. Activating mutations in TOR align with cancer-linked mutations in PI3KCalpha, guiding new drug design for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Target of Rapamycin (TOR) is a crucial kinase regulating cell growth.
- Understanding TOR's structure is key for developing targeted therapies.
Purpose of the Study:
- To model the catalytic region of TOR.
- To investigate the structural basis of TOR mutations.
- To explore potential drug targets for cancer therapy.
Main Methods:
- Comparative modeling using PI3KCgamma crystal structure.
- Analysis of activating and oncogenic mutations.
- Molecular docking of small molecule inhibitors (PP242, NVP-BEZ235, Ku-0063794).
Main Results:
- A structural model of the TOR catalytic region was generated.
- Activating TOR mutations identified in yeast correlate with oncogenic hotspots in PI3KCalpha.
- Inhibitor docking revealed novel pharmacophore interactions for specificity.
Conclusions:
- The TOR structural model offers insights into its regulation.
- The findings may aid in designing novel anticancer drugs targeting TOR.
- Understanding mutation patterns can inform drug development strategies.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...